Neurodegneration underlies the pathology of neurological disorders such as Alzheimer’s disease and Parkinson’s disease. The molecular events that initiate death of neurons in these diseases are incompletely understood. Identification of molecules that are elevated/activated and are required for neurodegeneration in cellular and animal models of diseases may provide us with novel endogenous targets for therapeutic intervention in these diseases.

​

​

To know more about what we do click the button below:

​